Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9VSQ

The TUG-891-bound structure of TMEM175

9VSQ の概要
エントリーDOI10.2210/pdb9vsq/pdb
EMDBエントリー65304
分子名称Endosomal/lysosomal proton channel TMEM175, 3-{4-[(4-fluoro-4'-methyl[1,1'-biphenyl]-2-yl)methoxy]phenyl}propanoic acid, CHOLESTEROL, ... (5 entities in total)
機能のキーワードtmem175, cro-em, tug-891, parkinson, lysosome, membrane protein
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数2
化学式量合計113110.25
構造登録者
Zhu, X.,Liu, H.,Yin, W. (登録日: 2025-07-09, 公開日: 2025-09-17, 最終更新日: 2025-11-19)
主引用文献Zhu, X.,Ping, M.,Liu, H.,Yu, T.,Jiang, Z.,Liu, Z.,Li, C.,Hou, X.,Chu, Q.,Li, S.,Mao, C.,Luo, T.,Kang, C.,Wang, F.,Yang, C.,Tang, M.,Jiang, Z.,Gao, Z.,Liu, H.,Xu, H.E.,Tang, B.,Cheng, X.,Yin, W.,Zhou, Y.,Li, P.
Structural insights into the activation of TMEM175 by small molecule.
Neuron, 113:3567-, 2025
Cited by
PubMed Abstract: The upregulation of transmembrane protein 175 (TMEM175) has the potential to improve Parkinson's disease (PD) by aiding in the removal of α-synuclein aggregates. Understanding the structural basis of TMEM175 agonisms is crucial for uncovering its therapeutic potential for PD. Here, we have identified the first cryo-electron microscopy (cryo-EM) structure of human TMEM175 complexes with three agonists: DCY1020, DCY1040, and TUG-891. An open state of TMEM175 is unequivocally captured, laying the groundwork for designing more effective agonists. Further investigations using surface plasmon resonance, systematic mutagenesis, whole-endolysosome patch-clamp techniques, and molecular dynamics simulations consistently revealed that DCY1020/1040 binds at the interface between two subunits, inducing an open conformation further augmented by the synergistic agonist TUG-891. Notably, these agonists facilitate the removal of pathological α-synuclein and restore functions of PD-related TMEM175 variants in neurons. Our findings provide proof of concept that drug discovery targeting TMEM175 can develop agonists capable of effectively reducing pathological α-synuclein levels in PD.
PubMed: 40865534
DOI: 10.1016/j.neuron.2025.07.029
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (2.74 Å)
構造検証レポート
Validation report summary of 9vsq
検証レポート(詳細版)ダウンロードをダウンロード

248942

件を2026-02-11に公開中

PDB statisticsPDBj update infoContact PDBjnumon